Introduction
Asthma is a chronic inflammatory airway disease characterized by reversible airflow obstruction, airway hyperresponsiveness, and recurrent respiratory symptoms.1 Despite advances in inhaled corticosteroids, bronchodilators, and biologics, asthma remains poorly controlled in many patients, prompting interest in complementary and traditional therapies.
One such controversial intervention is the “fish-based asthma therapy” (Fish Prasadam) practiced in Hyderabad, India. As reported in Nature Medicine, this annual mass treatment involves administration of a small live fish containing a secret herbal paste, consumed by patients with asthma in the belief of achieving long-term symptom relief or cure.
Description of the traditional intervention
The therapy is traditionally administered by a family who claim hereditary knowledge of the formulation. Key features include:
- Oral ingestion of a small live fish
- Insertion of a secret herbal preparation into the fish mouth before administration
- Annual mass distribution during a specific astrological period
- Recommendation of a restrictive diet for ~45 days after ingestion and repeated dosing over years2
Importantly, the exact composition of the herbal preparation has never been disclosed, limiting scientific evaluation.
Proposed therapeutic rationale (traditional claims)
The therapy is claimed to:
- “Cure” bronchial asthma over repeated annual doses
- Reduce wheezing and breathlessness
- Improve long-term respiratory health
However, no mechanistic framework consistent with respiratory pharmacology has been established, and the formulation remains unknown.
Possible mechanisms (scientifically speculative only)
Although unverified, hypothetical explanations include:
- Dietary restriction effect:
The post-treatment dietary regimen may reduce exposure to allergens and inflammatory foods, indirectly improving symptoms in some patients.
- Placebo and behavioral modulation:
Strong belief systems, ritualistic administration, and expectation of benefit may activate placebo-associated neuroimmune pathways.
- Nutritional contribution of fish
Fish contains omega-3 fatty acids with known anti-inflammatory effects, but the dose and bioavailability in this context are unknown and likely insufficient for asthma control.
Clinical evidence and evaluation status
Scientific evaluation of this therapy is severely limited:
- No randomized controlled trials exist
- Composition of the “medicine” is undisclosed
- Reproducibility is impossible due to lack of standardization
- Formal evaluation attempts have reportedly failed due to non-disclosure of ingredients
Systematic reviews of traditional asthma remedies highlight the absence of robust clinical evidence supporting fish-based interventions.
Therapeutic role in asthma (critical appraisal)
Based on current biomedical evidence:
- No proven bronchodilator or anti-inflammatory effect
- No validated impact on airway hyperresponsiveness
- No guideline endorsement in asthma management (GINA or equivalent frameworks)
At best, any perceived benefit is likely due to:
- Placebo response
- Dietary restriction effects
- Natural variability in asthma symptoms
Thus, it has no established therapeutic role in evidence-based asthma care.
Advantages (as reported in traditional practice)
From an ethnomedical perspective:
- High cultural acceptance in certain communities
- Low financial cost to participants
- Strong community-based participation and accessibility
- Reported subjective symptom relief in some users
Limitations and safety concerns
Lack of scientific validation:
- No published clinical trials or pharmacological characterization
Non-standardized intervention:
- Unknown active ingredients prevent dosing control and safety assessment
Risk of delayed medical care:
- Reliance may delay inhaled corticosteroid or bronchodilator therapy
Safety and hygiene concerns:
- Oral administration of live fish raises infection and choking risks in vulnerable individuals
Public health and ethical considerations
As highlighted in scientific commentary, regulatory agencies have struggled to evaluate the intervention due to lack of transparency and refusal to disclose formulation details, making it incompatible with standard clinical research frameworks.
This raises concerns regarding:
- Informed consent
- Evidence-based practice
- State endorsement of unverified therapies
Conclusion
Traditional fish-based asthma therapy represents a culturally embedded practice with strong public participation but minimal scientific substantiation. Current evidence does not support its efficacy in asthma management, and its therapeutic effects remain unproven and biologically implausible under standard pharmacological frameworks.
While dietary and psychosocial factors may contribute to perceived improvement, the therapy cannot be recommended as a substitute for evidence-based asthma treatment. Rigorous clinical research is not feasible without disclosure of composition, making its integration into modern respiratory medicine highly unlikely without substantial reformulation and scientific validation.
References:
- Zhao K, Nie H. Not every reversible airflow limitation is asthma. Chin Med J Pulm Crit Care Med. 2023;1(2):125-127. Published 2023 May 2. doi:10.1016/j.pccm.2023.04.002. https://pmc.ncbi.nlm.nih.gov/articles/PMC11332880/
- Jayaraman KS. Fishy asthma cure raises big stink in India. Nature Medicine. 2003 Jul 1;9(7):807-8. https://www.nature.com/articles/nm0703-807a